New funding for S.F. digital pharmacy firm sends its valuation to $1 billion

SoftBank?s Vision II Fund has led a Series D round for San Francisco delivery pharmacy Alto Pharmacy, vaulting its valuation over $1 billion unicorn mark, Reuters reported Thursday based on information from people familiar with the deal and from Delaware State filings. SoftBank?s Vision Fund II contributed around $250 million, according to Reuters, and other investors including Greenoaks Capital and Jackson Square Ventures also participated. Digital pharmacy companies like Alto are gaining?

Click to view original post